van de Loo J - Search Results

1

Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedure.

Cassens U, Ostkamp-Ostermann P, Garritsen H, Kelsch R, Ostermann H, Kienast J, Kiehl M, Buechner T, van de Loo J, Juergens H, Sibrowski W. Cassens U, et al. Among authors: van de loo j. Bone Marrow Transplant. 1997 Apr;19(8):835-40. doi: 10.1038/sj.bmt.1700754. Bone Marrow Transplant. 1997. PMID: 9134178

2

Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy.

Ostermann H, Rothenburger M, Mesters RM, van de Loo J, Kienast J. Ostermann H, et al. Among authors: van de loo j. Br J Haematol. 1994 Oct;88(2):332-7. doi: 10.1111/j.1365-2141.1994.tb05027.x. Br J Haematol. 1994. PMID: 7803278

3

Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.

Kienast J, Thompson SG, Raskino C, Pelzer H, Fechtrup C, Ostermann H, van de Loo J. Kienast J, et al. Among authors: van de loo j. Thromb Haemost. 1993 Oct 18;70(4):550-3. Thromb Haemost. 1993. PMID: 8115978

4

Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries.

Kienast J, Padró T, Steins M, Li CX, Schmid KW, Hammel D, Scheld HH, van de Loo JC. Kienast J, et al. Among authors: van de loo jc. Thromb Haemost. 1998 Mar;79(3):579-86. Thromb Haemost. 1998. PMID: 9531045

5

[Lysis therapy in deep leg vein thrombosis and pulmonary embolism after hip surgery?].

Kienast J, van de Loo J. Kienast J, et al. Among authors: van de loo j. Dtsch Med Wochenschr. 1991 Apr 26;116(17):676-7. Dtsch Med Wochenschr. 1991. PMID: 2019244 German. No abstract available.

6

Factors of the hemostatic system in diabetic patients. A survey of controlled studies.

Ostermann H, van de Loo J. Ostermann H, et al. Among authors: van de loo j. Haemostasis. 1986;16(6):386-416. doi: 10.1159/000215317. Haemostasis. 1986. PMID: 3556346 Review.

7

[Platelet inhibitors or anticoagulants in prevention after myocardial infarct? The 1991 state of the art].

van de Loo J, Kienast J. van de Loo J, et al. Z Gesamte Inn Med. 1992 Jan;47(1):1-5. Z Gesamte Inn Med. 1992. PMID: 1570716 Review. German.

8

[Anti-phospholipid antibody with recurrent venous thromboembolism and severe autoimmune thrombocytopenia].

Kienast J, Ostermann H, Stenzinger W, Kötter EM, van de Loo J. Kienast J, et al. Among authors: van de loo j. Klin Wochenschr. 1989 Jul 3;67(13):691-5. doi: 10.1007/BF01718033. Klin Wochenschr. 1989. PMID: 2502650 German.

9

Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.

Ostermann H, Schmitz-Huebner U, Windeler J, Bär F, Meyer J, van de Loo J. Ostermann H, et al. Among authors: van de loo j. Eur Heart J. 1992 Sep;13(9):1225-32. doi: 10.1093/oxfordjournals.eurheartj.a060341. Eur Heart J. 1992. PMID: 1396833 Clinical Trial.

10

Different pathways initiating arachidonic acid (AA) release/thromboxane (TxA2) formation in human platelets--studies with fluoride and phorbol ester.

Lenfers B, Kienast J, van de Loo J. Lenfers B, et al. Among authors: van de loo j. Prog Clin Biol Res. 1989;301:309-14. Prog Clin Biol Res. 1989. PMID: 2552463 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters